SCHEMBL5085510

SCHEMBL5085510

CCOC(=O)/C(=C\CC(C)C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.46
GLO1 Q04760 1/20 0.46
ALDH1A1 P00352 3/20 0.44
CYP2D6 P10635 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
S1PR4 O95977 1/20 0.40
S1PR1 P21453 1/20 0.40
MAPK1 P28482 1/20 0.40
GRIK1 P39086 1/20 0.39
GAA P10253 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
DHODH Q02127 3/20 0.36
EGLN1 Q9GZT9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5085513 1.00 NPSR1 (0.46) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL1408810 0.90 NPSR1 (0.50) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL11719302 0.85 GLO1 (0.60) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL11719294 0.85 GLO1 (0.60) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL1409891 0.80 GRIK1 (0.48) ALDH1A1CYP2D6GRIK1TDP1CYP2C19
SCHEMBL1408813 0.79 GRIK1 (0.37) MAPTGRIK1
SCHEMBL6690520 0.77 NPSR1 (0.48) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL28582961 0.77 CYP2D6 (0.45) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL2474497 0.76 NPSR1 (0.56) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL28072 0.76 NPSR1 (0.38) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008062460-A2 CRYSTALLINE FORMS OF PREGABALIN CADILA HEALTHCARE LIMITED (IN) 2008-05-29 WO claimed
WO-2012093411-A2 PROCESS FOR THE PREPARATION OF R-(-)-3- (CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND THE INTERMEDIATES DR BRAJA SUNDAR PRADHAN (IN) 2012-07-12 WO disclosed
WO-2010070593-A2 MALONATE ESTERS PFIZER IRELAND PHARMACEUTICALS (IE) 2010-06-24 WO disclosed
WO-2008062460-A2 CRYSTALLINE FORMS OF PREGABALIN CADILA HEALTHCARE LIMITED (IN) 2008-05-29 WO disclosed